Dr. Kirk Lozada details how tip-plasty can benefit patients with isolated nasal tip concerns and explores criteria for safe, ...

Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet ...

Meaningful Fatigue score reduction seen in study is a critically important quality of life (QoL) measure for Multiple Sclerosis patients.All patients experienced stabilization of Expanded Disability ...

The UK government has announced a new free trade agreement with India. The ABPI is disappointed that the deal does not appear to address longstanding industry concerns about intellectual property ...

A New Chapter in Global Health Innovation Begins BEIJING, CHINA AND ATLANTA, GA / ACCESS Newswire / May 7, 2025 / In a landmark collaboration marking a leap in digital health innovation, LifeQ has ...

Crofelemer is the only oral drug approved by the FDA's Center for Drug Evaluation and Research under Botanical GuidanceClick here to access replay of company's April 30, 2025 investor webcast SAN ...

Ryan Howells and Ryan Smith bring extensive expertise in digital health innovation and interoperability WASHINGTON, DC / ACCESS Newswire / May 7, 2025 / DirectTrust®, a non-profit healthcare industry ...

Founder of ESSE Care and leading endometriosis specialist recognized for her leadership in minimally invasive gynecologic surgery and integrative reproductive health care MANHATTAN, NEW YORK / ACCESS ...

AstraZeneca and Daiichi Sankyo’s Enhertu followed by THP showed an improved safety profile vs. standard of careFirst Phase III trial to demonstrate benefit of Enhertu in early breast cancer Positive ...

BEIJING, CHINA / ACCESS Newswire / May 7, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and ...

Lupus presents unique challenges, particularly for patients with lupus nephritis — a severe form of the condition that affects kidney function and quality of life. Current treatments often come with ...

Viatris Inc. (Nasdaq: VTRS) today announced that on May 5, 2025, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common ...